Filter Results:
(61)
Show Results For
- All HBS Web
(61)
- News (15)
- Research (32)
- Multimedia (1)
- Faculty Publications (21)
Show Results For
- All HBS Web
(61)
- News (15)
- Research (32)
- Multimedia (1)
- Faculty Publications (21)
- 15 Apr 2014
- First Look
First Look: April 15
Purchase this case: http://hbr.org/product/pepsico-profits-and-food-the-belt-tightens/an/314055-PDF-ENG Harvard Business School Case 313-012 Cancer Treatment Centers of America® (A) Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned... View Details
Keywords: Sean Silverthorne
- 07 Jun 2016
- First Look
June 7, 2016
strategic, financial, and operational objectives. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51110 May 2016 Oncology How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer... View Details
Keywords: Sean Silverthorne
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- July 2021 (Revised July 2022)
- Case
Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care
By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab
Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’... View Details
Keywords: Health Care and Treatment; Outcome or Result; Cost Management; Activity Based Costing and Management; Mobile and Wireless Technology; Health Testing and Trials; Surveys; Health Industry; Boston
Kaplan, Robert S., Navraj S. Nagra, and Syed S. Shehab. "Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care." Harvard Business School Case 122-010, July 2021. (Revised July 2022.)
- Web
Capstone - MBA
medicine, microbiomes, opioid use disorder, organoid systems for drug development, oncology, psychedelics, women’s health, and many more. Recent Capstone Projects iPSC-Derived NK Cells – Changing Cancer’s Fate Richard Nixon declared a war on cancer in 1971, but View Details
- Web
Faculty & Advisors - MBA
University; SB/SM, Massachusetts Institute of Technology Chris leads MPM Capital’s public market investing as portfolio manager for BioImpact Equities (formerly known as Burrage Capital) and the Oncology Impact Funds. Previously, Chris... View Details
- September 2017 (Revised February 2023)
- Case
Intermountain Healthcare: Pursuing Precision Medicine
By: Richard G. Hamermesh, Kathy E. Giusti, Robert S. Huckman and Julia Kelley
Headquartered in Salt Lake City, Intermountain Healthcare operates 23 hospitals and hundreds of clinics in Utah and Idaho and provides insurance to approximately 850,000 patients through its insurance arm, SelectHealth. In 2013, Intermountain, known for its commitment... View Details
Keywords: Precision Medicine; Healthcare; Innovation; Cancer; Cancer Research; Health Care; Technology; Health Care and Treatment; Innovation Leadership; Disruptive Innovation; Entrepreneurship; Decision Choices and Conditions; Health Industry; Insurance Industry; Utah; United States; North America
Hamermesh, Richard G., Kathy E. Giusti, Robert S. Huckman, and Julia Kelley. "Intermountain Healthcare: Pursuing Precision Medicine." Harvard Business School Case 818-018, September 2017. (Revised February 2023.)
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
all stakeholders. Stephen Linderman MD, PhD 2019 Stephen Linderman is the CEO and co-founder of Absco Therapeutics (AbscoTx), an immune oncology company specializing in image-guided, intratumoral drug delivery. AbscoTx is based on... View Details
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 13 Jul 2023
- News
The Network Effect
between the two companies. In March 2021, Model was a part of the Agios team that finalized the sale of the biotech’s oncology portfolio to international pharmaceutical company Servier. For Agios, the sale was part of a pivot from cancer... View Details
- 22 Mar 2021
- Research & Ideas
How to Learn from the Big Mistake You Almost Make
Steinberg, and Ann Raldow, and medical physicist Nzhde Agazaryan. A spectrum of close calls The research team wanted to understand the role of psychological safety—defined as “the shared belief that interpersonal risk-taking is safe”—in determining the likelihood that... View Details
- Web
Geography of Care - Institute For Strategy And Competitiveness
basis with respect to concordance with MD Anderson clinical care guidelines for different cancer conditions. These tended to be relatively small medical oncology practices. They then expanded further by affiliating with large partner... View Details
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
personalized oncology care. They have collectively raised more than $500M in funding and an additional $244M from an IPO in June 2020. The fellowship is guided by Peter Barrett, executive fellow, and a Key Advisory Board of 13 seasoned... View Details
- Web
Faculty & Advisors - MBA
supporting her spouse and two vivacious children. Bill Doyle MBA ‘92, Harvard University; S.B., Materials Science and Engineering, MIT Bill is the Executive Chairman of Novocure Ltd., a commercial stage oncology company pioneering Tumor... View Details
- Web
Recruiting Partners - Health Care
Services Bayer Corporation Bayside Oncology Beacon Health Options Beckman Coulter, Inc. Becton, Dickinson & Co. Behavioral Intervention Association (BIA) Bethesda Hospital Foundation Beth Israel Deaconess Medical Center Bill & Melinda... View Details
- Career Coach
Alan Braly
strategies, and product roadmaps in areas of innovation with a current emphasis on oncology data science and data products. Along the way, he has been a leader, manager, mentor, coach, and sounding board for early and mid-career folks... View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
peer-reviewed and practitioner journals. Dr. Guinan is one of our co-directors at LISH and she is a professor in radiation oncology at HMS and the Dana-Farber Cancer Institute. Part of the lab’s mission is to address problems with... View Details
- Web
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows - MBA
Blog Blog MBA Voices Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Career and Professional Development Staff Author HBS Community Author HBS Faculty Author MBA Admissions Author MBA Students Topics Topics 1st Year (RC) 2+2 Program 2nd Year... View Details
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
makeup. While oncology currently leads the way in precision medicine, therapies are also available to treat cystic fibrosis, for example; and the field has the potential to impact treatment of all diseases, including crippling... View Details
- 01 Sep 2014
- News
Making a Statement
says. The cofounder and managing partner of Enhanced Equity Funds, Paul speaks from experience. His 30-year career has been devoted almost entirely to health care. As an example of how innovation enhances care, Paul cites an oncology... View Details